Beta-ureidopropionase deficiency
General Information (adopted from Orphanet):
Synonyms, Signs: |
Beta-alanine synthase deficiency |
Number of Symptoms | 31 |
OrphanetNr: | 65287 |
OMIM Id: |
613161
|
ICD-10: |
E79.8 |
UMLs: |
C1291512 |
MeSH: |
|
MedDRA: |
|
Snomed: |
124511000 |
Prevalence, inheritance and age of onset:
Prevalence: | 5 cases [Orphanet] |
Inheritance: |
Autosomal recessive [Orphanet] |
Age of onset: |
Neonatal Infancy [Orphanet] |
Disease classification (adopted from Orphanet):
Parent Diseases: |
AARSKOG SYNDROME, AUTOSOMAL DOMINANT
-AARSKOG SYNDROME, AUTOSOMAL DOMINANT Disorder of pyrimidine metabolism -Rare genetic disease Metabolic neurotransmission anomaly with epilepsy -Rare neurologic disease Neurometabolic disease -Rare genetic disease -Rare neurologic disease |
Symptom Information:
|
(HPO:0000072) | Hydroureter | 146 / 7739 | ||||
|
(HPO:0002836) | Bladder exstrophy | 8 / 7739 | ||||
|
(HPO:0000048) | Bifid scrotum | 1/6 [HPO:skoehler] | 36 / 7739 | |||
|
(HPO:0000252) | Microcephaly | 1/6 [HPO:skoehler] | 832 / 7739 | |||
|
(HPO:0001327) | Photomyoclonic seizures | 125 / 7739 | ||||
|
(HPO:0002133) | Status epilepticus | 1/6 [HPO:skoehler] | 59 / 7739 | |||
|
(HPO:0002167) | Neurological speech impairment | 308 / 7739 | ||||
|
(HPO:0001249) | Intellectual disability | 2/6 [HPO:skoehler] | 1089 / 7739 | |||
|
(HPO:0001250) | Seizures | 1245 / 7739 | ||||
|
(HPO:0002521) | Hypsarrhythmia | 1/6 [HPO:skoehler] | 43 / 7739 | |||
|
(HPO:0001332) | Dystonia | 197 / 7739 | ||||
|
(HPO:0002650) | Scoliosis | 1/6 [HPO:skoehler] | 705 / 7739 | |||
|
(HPO:0002023) | Anal atresia | 1/6 [HPO:skoehler] | 135 / 7739 | |||
|
(HPO:0100548) | Exstrophy | 4 / 7739 | ||||
|
(HPO:0001319) | Neonatal hypotonia | 101 / 7739 | ||||
|
(HPO:0002188) | Delayed CNS myelination | 16 / 7739 | ||||
|
(OMIM) | Absence of beta-ureidopropionase activity and protein in liver biopsy | 1 / 7739 | ||||
|
(OMIM) | Increased urinary, plasma, and CSF dihydrothymine | 1 / 7739 | ||||
|
(OMIM) | Pelvicalyceal dilatation | 3 / 7739 | ||||
|
(OMIM) | Increased urinary, plasma, and CSF N-carbamyl-beta-alanine | 1 / 7739 | ||||
|
(OMIM) | Increased urinary, plasma, and CSF N-carbamyl-beta-aminoisobutyric acid | 1 / 7739 | ||||
|
(OMIM) | MRI shows delayed myelination (1 of 6 patients) | 1 / 7739 | ||||
|
(OMIM) | Increased urinary dihydropyrimidines | 1 / 7739 | ||||
|
(OMIM) | Duplicated appendix and distal colon (in 1 of 6 patients) | 1 / 7739 | ||||
|
(OMIM) | Normal development | 4 / 7739 | ||||
|
(OMIM) | Increased urinary, plasma, and CSF dihydrouracil | 1 / 7739 | ||||
|
(OMIM) | Delayed psychomotor development, severe | 14 / 7739 | ||||
|
(OMIM) | EEG shows hypsarrhythmia | 4 / 7739 | ||||
|
(HPO:0000007) | Autosomal recessive inheritance | 2538 / 7739 | ||||
|
(OMIM) | Bifid phallus (in 1 of 6 patients) | 1 / 7739 | ||||
|
(HPO:0003593) | Infantile onset | 249 / 7739 |
Associated genes:
UPB1; |
ClinVar (via SNiPA)
Gene symbol | Variation | Clinical significance | Reference |
---|
Additional Information:
Description: (OMIM) |
Beta-ureidopropionase deficiency is a very rare autosomal recessive inborn error of metabolism due to a defect in pyrimidine degradation. Less than 10 patients have been reported, and the phenotype can range from severe neurologic involvement with mental retardation and ... |
Clinical Description OMIM |
Assmann et al. (1998) reported a 17-month-old girl who presented with muscular hypotonia, dystonic movements, scoliosis, microcephaly, and severe developmental delay. Biochemical studies showed increased N-carbamyl-beta-alanine and N-carbamyl-beta-aminoisobutyric acid in plasma, urine, and cerebrospinal fluid (CSF). Van Kuilenburg et ... |
Molecular genetics OMIM |
Van Kuilenburg et al. (2004) reported 3 mutant alleles in the UPB1 gene among 4 patients with beta-ureidopropionase deficiency, including the original patient described by Assmann et al. (1998) (606673.0001-606673.0003). The authors speculated that an altered homeostasis of beta-aminoisobutyric ... |